Exchange Traded Concepts’s Meridian Bioscience Inc VIVO Stock Holding History

Exchange Traded Concepts’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-55,898	Closed	-$1.86M	–	1319
2022 Q4	$1.86M	Buy	55,898 +732	+1%	+$23.6K	0.05%	192
2022 Q3	$1.74M	Buy	55,166 +15,048	+38%	+$487K	0.06%	167
2022 Q2	$1.22M	Sell	40,118 -5,004	-11%	-$135K	0.04%	257
2022 Q1	$1.17M	Buy	+45,122	New	+$1.07M	0.02%	313
2021 Q3	–	Sell	-45,503	Closed	-$1.01M	–	1283
2021 Q2	$1.01M	Buy	45,503 +4,330	+11%	+$91.8K	0.03%	321
2021 Q1	$1.08M	Buy	41,173 +13,992	+51%	+$333K	0.04%	269
2020 Q4	$508K	Buy	27,181 +2,658	+11%	+$49.6K	0.02%	355
2020 Q3	$416K	Sell	24,523 -5,196	-17%	-$101K	0.02%	338
2020 Q2	$692K	Buy	+29,719	New	+$431K	0.11%	145

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Exchange Traded Concepts's VIVO Position: Q1 2023 in Review

Exchange Traded Concepts sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 55,898 shares — an estimated $1.86M sold.

Exchange Traded Concepts first reported a position in VIVO in Q2 2020 and held it in 9 quarters. The position peaked at $1.86M in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Exchange Traded Concepts reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Exchange Traded Concepts sold 55,898 Meridian Bioscience Inc shares in Q1 2023, an estimated $1.86M.
Exchange Traded Concepts first reported a position in Meridian Bioscience Inc in Q2 2020 and held it in 9 quarters.
Exchange Traded Concepts's Meridian Bioscience Inc position peaked at $1.86M in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Exchange Traded Concepts's 13F filing for Q1 2023, filed 12 Apr 2023.